Comorbid Depression among Untreated Illicit Opiate Users: Results from a Multisite Canadian Study
暂无分享,去创建一个
J. Rehm | N. el-Guebaly | T. Wild | S. Brochu | J. Bruneau | M. Tyndall | S. Brissette | B. Fischer | L. Noël | P. Mun
[1] Nicholas Walliman,et al. Social research methods , 2006 .
[2] F. Leri,et al. Patterns of opioid and cocaine co-use: a descriptive study in a Canadian sample of untreated opioid-dependent individuals. , 2005, Experimental and clinical psychopharmacology.
[3] Jennifer L. Anthony,et al. Pharmacotherapy plus psychotherapy for treatment of depression in active injection drug users. , 2004, Archives of general psychiatry.
[4] T. Brugha,et al. Substance misuse and psychiatric comorbidity: an overview of the OPCS National Psychiatric Morbidity Survey. , 1998, International review of psychiatry.
[5] F. Leri,et al. Understanding polydrug use: review of heroin and cocaine co-use. , 2003, Addiction.
[6] F. Smit,et al. Risk factors for 12-month comorbidity of mood, anxiety, and substance use disorders: findings from the Netherlands Mental Health Survey and Incidence Study. , 2002, The American journal of psychiatry.
[7] C. Moore,et al. Comparison of point-of-collection screening of drugs of abuse in oral fluid with a laboratory-based urine screen. , 2001, Forensic science international.
[8] C. Latkin,et al. Longitudinal predictors of depressive symptoms among low income injection drug users , 2001, AIDS care.
[9] A. Swain,et al. COMORBIDITY IN A CLINICAL SAMPLE OF SUBSTANCE ABUSERS , 2001, The American journal of drug and alcohol abuse.
[10] A. Bryman. Social Research Methods , 2001 .
[11] W. Compton,et al. Psychiatric disorders among drug dependent subjects: are they primary or secondary? , 2000, The American journal on addictions.
[12] L B Cottler,et al. Substance dependence and other psychiatric disorders among drug dependent subjects: race and gender correlates. , 2000, The American journal on addictions.
[13] S. Patten,et al. Performance of the composite international diagnostic interview short form for major depression in a community sample. , 2000, Chronic diseases in Canada.
[14] Olga V. Demler,et al. Cross-national comparisons of the prevalences and correlates of mental disorders. WHO International Consortium in Psychiatric Epidemiology. , 2000, Bulletin of the World Health Organization.
[15] R. Kessler,et al. Psychiatric epidemiology: selected recent advances and future directions. , 2000, Bulletin of the World Health Organization.
[16] C. Latkin,et al. Depressive symptoms, drug network, and their synergistic effect on needle-sharing behavior among street injection drug users. , 1999, The American journal of drug and alcohol abuse.
[17] R. Kessler,et al. The World Health Organization Composite International Diagnostic Interview short‐form (CIDI‐SF) , 1998 .
[18] Beth E. Molnar,et al. Comorbidity of substance use disorders with mood and anxiety disorders: results of the International Consortium in Psychiatric Epidemiology. , 1998, Addictive behaviors.
[19] Charles B. Fleming,et al. A meta-analysis of predictors of continued drug use during and after treatment for opiate addiction. , 1998, Addiction.
[20] E. Isometsä,et al. Depression in Finland: a computer assisted telephone interview study , 1997, Acta psychiatrica Scandinavica.
[21] R. Kessler,et al. Lifetime co-occurrence of DSM-III-R alcohol abuse and dependence with other psychiatric disorders in the National Comorbidity Survey. , 1997, Archives of general psychiatry.
[22] R. Brooner,et al. Psychiatric and substance use comorbidity among treatment-seeking opioid abusers. , 1997, Archives of general psychiatry.
[23] D. Offord,et al. One-Year Prevalence of Psychiatric Disorder in Ontarians 15 to 64 Years of Age , 1996, Canadian journal of psychiatry. Revue canadienne de psychiatrie.
[24] J. Lieberman,et al. Incidence and Correlates of Tardive Dyskinesia in First Episode of Schizophrenia , 1996 .
[25] J. Berg. Book Review: Screening for Down's Syndrome , 1996 .
[26] R. Kessler,et al. The epidemiology of co-occurring addictive and mental disorders: implications for prevention and service utilization. , 1996, The American journal of orthopsychiatry.
[27] J. Gorman,et al. Psychopathology in male and female intravenous drug users with and without HIV infection. , 1994, The American journal of psychiatry.
[28] R. Kessler,et al. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. , 1994, Archives of general psychiatry.
[29] Chuan Yi Tang,et al. A 2.|E|-Bit Distributed Algorithm for the Directed Euler Trail Problem , 1993, Inf. Process. Lett..
[30] C. Robert Cloninger,et al. Psychiatric comorbidity and suicidality among intravenous drug users. , 1992, The Journal of clinical psychiatry.
[31] G. Woody,et al. Risk factors for needle sharing among methadone-treated patients. , 1991, The American journal of psychiatry.
[32] D S Rae,et al. Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study. , 1990, JAMA.
[33] R. Bland,et al. LIFETIME PREVALENCE OF PSYCHIATRIC DISORDERS IN EDMONTON , 1988, Acta psychiatrica Scandinavica. Supplementum.
[34] B. Rounsaville,et al. A 2.5-year follow-up of depression, life crises, and treatment effects on abstinence among opioid addicts. , 1986, Archives of general psychiatry.
[35] B. Rounsaville,et al. Untreated opiate addicts. How do they differ from those seeking treatment? , 1985, Archives of general psychiatry.
[36] M. Weissman,et al. Diagnosis and symptoms of depression in opiate addicts. Course and relationship to treatment outcome. , 1982, Archives of general psychiatry.
[37] M. Weissman,et al. Heterogeneity of psychiatric diagnosis in treated opiate addicts. , 1982, Archives of general psychiatry.